CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer

There is an urgent need for identification of new prognostic markers and therapeutic targets for non-small cell lung cancer (NSCLC). In this study, we evaluated immune cells markers in 100 NSCLC specimens. Immunohistochemical analysis revealed no prognostic value for the markers studied, except CD16...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovaleva, Olga V., Rashidova, Madina A., Samoilova, Daria V., Podlesnaya, Polina A., Tabiev, Rasul M., Mochalnikova, Valeria V., Gratchev, Alexei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795388/
https://www.ncbi.nlm.nih.gov/pubmed/33466316
http://dx.doi.org/10.3390/ijms22010450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795388/
https://www.ncbi.nlm.nih.gov/pubmed/33466316
http://dx.doi.org/10.3390/ijms22010450

Ejemplares similares